Entero Cost Of Revenue from 2010 to 2025

ENTERO Stock   1,321  20.70  1.59%   
Entero Healthcare's Cost Of Revenue is increasing over the years with slightly volatile fluctuation. Cost Of Revenue is expected to dwindle to about 26 B. From 2010 to 2025 Entero Healthcare Cost Of Revenue quarterly data regression line had arithmetic mean of  19,997,884,381 and r-squared of  0.69. View All Fundamentals
 
Cost Of Revenue  
First Reported
2010-12-31
Previous Quarter
41.1 B
Current Value
26 B
Quarterly Volatility
10.4 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Entero Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entero Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 197 M, Selling General Administrative of 1.8 B or Selling And Marketing Expenses of 49 M, as well as many indicators such as . Entero financial statements analysis is a perfect complement when working with Entero Healthcare Valuation or Volatility modules.
  
This module can also supplement various Entero Healthcare Technical models . Check out the analysis of Entero Healthcare Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Entero Stock

Entero Healthcare financial ratios help investors to determine whether Entero Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entero with respect to the benefits of owning Entero Healthcare security.